Skip to main content
Fig. 4 | Molecular Brain

Fig. 4

From: Aβ42 treatment of the brain side reduced the level of flotillin from endothelial cells on the blood side via FGF-2 signaling in a blood–brain barrier model

Fig. 4

The Aβ42 treatment-induced decrease in the secretion of flotillin on the blood side was restored by the addition of FGF-2. A Protein levels were determined by western blotting and quantified by densitometry. B, C Statistical significance was calculated using one-way ANOVA and the Tukey test (*p < 0.05). Data are shown as the mean ± SD (n = 3)

Back to article page

Molecular Brain

ISSN: 1756-6606